Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeeme...
December 02 2019 - 7:01AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING AND/OR
REGISTRATION UNDER SECTION 12(b) OF THE
SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 001-34912
Celgene Corporation
NASDAQ Global Market
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
86 Morris Avenue, Summit, New Jersey, 07901
(908) 673-9000
(Address, including zip code, and telephone number, including area code,
of Issuer’s principal executive offices)
Contingent Value Rights
(Description of class of securities)
Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
Pursuant to the requirements of the Securities Exchange Act of 1934, Celgene Corporation certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused
this notification to be signed on its behalf by the undersigned duly authorized person.
1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
Celgene (NASDAQ:CELGZ)
Historical Stock Chart
From Aug 2024 to Sep 2024
Celgene (NASDAQ:CELGZ)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about Celgene Corporation (NASDAQ): 0 recent articles
More Celgene Corp /de/ News Articles